SUVENPHAR

Suven Life Sciences, a small-cap player in the Pharmaceuticals and Drugs industry, has recently experienced a shift in its technical trend from mildly bearish to bearish. The company's current stock price stands at 103.10, down from a previous close of 108.00. Over the past year, Suven Life Sciences has seen a 52-week high of 169.00 and a low of 83.27, indicating significant volatility. The technical summary reveals several bearish indicators. The MACD shows a bearish trend on a weekly basis and mildly bearish on a monthly basis. The Relative Strength Index (RSI) indicates no signal for both weekly and monthly periods. Bollinger Bands also reflect a bearish stance in both time frames. Daily moving averages are bearish, while the KST shows a bearish trend weekly but bullish monthly. Dow Theory indicates a mildly bearish trend for both weekly and monthly periods, and the On-Balance Volume (OBV) is mildly bearish weekly but bullish monthly. In terms of returns, Suven Life Sciences has underperformed compared to the Sensex in various time frames. Over the past week, the stock returned -11.99% compared to the Sensex's -2.81%. Year-to-date, the company has seen a decline of 19.86%, while the Sensex has dropped only 6.32%. However, over a longer horizon, such as 10 years, Suven Life Sciences has delivered a remarkable return of 559.29%, significantly outperforming the Sensex's 149.30%.